Eleftheria Zeggini obtained a BSc in Biochemistry and a PhD in Immunogenetics of Juvenile Arthritis from the University of Manchester. In 2004, she joined the Wellcome Centre for Human Genetics in Oxford to work on the genetics of type 2 diabetes, and on design, analysis and interpretation issues in large-scale association studies. In 2008, she joined the Wellcome Sanger Institute Human Genetics Faculty and in 2018 moved to Munich as founding director of the Institute of Translational Genomics at the Helmholtz Zentrum München. In 2020, she was also appointed Chair of Translational Genomics at the TUM School of Medicine and received the TUM Liesel Beckmann Distinguished Professorship. Her research leverages big data and aims to translate insights from genomics into mechanisms of disease development and progression, shortening the path to translation and empowering precision medicine.